Article
The impact of gene profiling in chronic myeloid leukaemia.
Best practice & research. Clinical haematology - 1 Jun 2009
Yong Agnes S M, Melo Junia V
Abstract excerpt
The use of microarray technology in chronic myeloid leukaemia (CML) has increased our understanding of the biology of this disease. From early studies of gene expression profiling in BCR-ABL-positive cell lines to samples from patients in different disease phases of CML, using resting cells or cells treated with a variety of therapeutic agents, the field has now moved on to profiling microRNA and single...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
